Aim The novel coronavirus infection (COVID-19), now a worldwide public health concern is
associated with varied fatality. Patients with chronic underlying conditions like diabetes and …

Background & aims Coronavirus disease 2019 (COVID-19) spreads rapidly and within no
time, it has been declared a pandemic by the World Health Organization. Evidence suggests …

BACKGROUND Diabetes mellitus (DM) is associated with adverse clinical outcomes and
high mortality in patients with coronavirus disease 2019 (COVID-19). The relationship …

Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

The pandemic of COVID‐19, a disease caused by a novel coronavirus SARS‐CoV‐2, is
associated with significant morbidity and mortality. Recent data showed that hypertension …

Aims To estimate the prevalence of established diabetes and its association with the clinical
severity and in-hospital mortality associated with COVID-19. Data synthesis We …

It is widely recognized that hypertension is one of the major risk factor for disease severity
and mortality in patients with coronavirus disease 2019 (COVID‐19). However, type 2 …

Abstract Coronavirus disease 2019 (Covid-19) has affected millions of people and may
disproportionately affect those with hypertension and diabetes. Because of inadequate …

Aims Nowadays, the ongoing pandemic of COVID-19 caused by the novel coronavirus
Syndrome-Coronavirus-2 (SARS-CoV-2) is an emerging, rapidly evolving situation …

Background Diabetes is a cardiometabolic comorbidity that may predispose COVID‐19
patients to worse clinical outcomes. This study sought to determine the prevalence of …